Switch to:
Cascadian Therapeutics Inc (NAS:CASC)
EV/EBITDA
-0.84 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Cascadian Therapeutics Inc's enterprise value is $52.40 Mil. Cascadian Therapeutics Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Sep. 2016 was $-62.75 Mil. Therefore, Cascadian Therapeutics Inc's EV/EBITDA ratio for today is -0.84.

During the past 13 years, the highest EV/EBITDA Ratio of Cascadian Therapeutics Inc was 9.80. The lowest was -8605.40. And the median was -2.00.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Cascadian Therapeutics Inc's stock price is $5.50. Cascadian Therapeutics Inc's earnings per share for the trailing twelve months (TTM) ended in Sep. 2016 was $-3.54. Therefore, Cascadian Therapeutics Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Cascadian Therapeutics Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=52.402/-62.754
=-0.84

Cascadian Therapeutics Inc's current Enterprise Value is $52.40 Mil.
Cascadian Therapeutics Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Sep. 2016 was -8.992 (Dec. 2015 ) + -12.807 (Mar. 2016 ) + -30.32 (Jun. 2016 ) + -10.635 (Sep. 2016 ) = $-62.75 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Cascadian Therapeutics Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=5.50/-3.54
=

Cascadian Therapeutics Inc's share price for today is $5.50.
Cascadian Therapeutics Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Sep. 2016 was -0.6 (Dec. 2015 ) + -0.84 (Mar. 2016 ) + -1.56 (Jun. 2016 ) + -0.54 (Sep. 2016 ) = $-3.54.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Cascadian Therapeutics Inc Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
ev2ebitda -3.99-1.04-0.43-6.31-3.40-6.53-11.08-1.58-2.31-4.80

Cascadian Therapeutics Inc Quarterly Data

Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16
ev2ebitda -5.94-3.16-2.31-1.81-5.51-3.86-4.80-2.00-0.79-2.39
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK